scispace - formally typeset
A

Axel Fürstberger

Researcher at University of Ulm

Publications -  15
Citations -  82

Axel Fürstberger is an academic researcher from University of Ulm. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 10 publications receiving 35 citations.

Papers
More filters
Journal ArticleDOI

Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling.

TL;DR: Investigation of the activity of the BCL-2 inhibitor venetoclax in B-cell precursor acute lymphoblastic leukemia and found heterogeneous sensitivities in BCP-ALL cell lines and in a series of patient-derived primografts identified parameters of sensitivity and resistance, which provide information for stratification and clinical guidance in future clinical applications of VEN in patients with ALL.
Journal ArticleDOI

Interaction Empowerment in Mobile Health: Concepts, Challenges, and Perspectives

TL;DR: Existing approaches of individual empowerment are examined and a different view of empowerment in digital health, namely interaction empowerment is analyzed, which could positively influence intersectoral communication and facilitate secure data and knowledge sharing.
Journal ArticleDOI

3D Network exploration and visualisation for lifespan data

TL;DR: A new Javascript 3D network viewer JANet is developed that provides the proposed visualisation strategies and has a customised interface for AgeFactDB data that allows gaining deeper insights into lifespan data patterns not accessible by common database queries alone.
Journal ArticleDOI

Supporting Medical Staff from Psycho-Oncology with Smart Mobile Devices: Insights into the Development Process and First Results.

TL;DR: In this paper, the authors developed a mobile application, FeelBack, which is designed to support data collection that is based on well-known and approved psychological instruments, which can be used to optimize treatment.
Journal ArticleDOI

CHD5 inhibits metastasis of neuroblastoma.

TL;DR: In this paper, the role of CHD5 in metastasis was investigated in neuroblastoma (NB) and confirmed that low expression was associated with stage 4 stage 4 NB.